Expertise in
13
conditions

Filippo Pietrantonio

Milan, IT 
Expertise in
13
conditions
Milan, IT 

Overview

Filippo Pietrantonio practices practicing medicine in Milan, Italy.

Mr. Pietrantonio is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Stomach Cancer, Pseudomyxoma Peritonei, Hepato-Pancreato-Biliary Surgery, and Hepatectomy.

He is actively involved in clinical research, co-authoring 404 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Milan, Italy
Other Locations
Rome, Italy
Via Giacomo Venezian 1, Via, 20133, Italy
Padova, Italy
70124, Italy
Bari, Italy
Verona, 37100, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase I/II Study Exploring the Safety and Activity of Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients
A Phase I/II Study Exploring the Safety and Activity of Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: May 20, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial
Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial
Enrollment Status: Unknown
Publish Date: September 28, 2023
Intervention Type: Drug
Study Drugs: CAPOX, Capecitabine, FOLFIRI
Study Phase: Phase 2
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Combination in Microsatellite Stable (MSS), MGMT Silenced Metastatic Colorectal Cancer (mCRC): the MAYA Study
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Combination in Microsatellite Stable (MSS), MGMT Silenced Metastatic Colorectal Cancer (mCRC): the MAYA Study
Enrollment Status: Completed
Publish Date: April 04, 2022
Intervention Type: Drug
Study Phase: Phase 2
Open-label, Randomized, Multicenter, Phase II Trial to Compare Efficacy of CAPTEM Versus FOLFIRI as Second Line in Patients Progressed on or After First-line Oxaliplatin Chemo for Advanced, MGMT Methylated, RAS Mutated Colorectal Cancer
Open-label, Randomized, Multicenter, Phase II Trial to Compare Efficacy of CAPTEM Versus FOLFIRI as Second Line in Patients Progressed on or After First-line Oxaliplatin Chemo for Advanced, MGMT Methylated, RAS Mutated Colorectal Cancer
Enrollment Status: Completed
Publish Date: September 09, 2021
Intervention Type: Drug
Study Phase: Phase 2
PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES
PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES
Enrollment Status: Completed
Publish Date: August 07, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

404 Total Publications

Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.
Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.
Journal: ESMO gastrointestinal oncology
Published: August 28, 2026

Frequently Asked Questions about Filippo Pietrantonio

Is Filippo Pietrantonio a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Filippo Pietrantonio is classified as an Elite expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Filippo Pietrantonio participate in research or clinical trials?

Yes. Filippo Pietrantonio has published 404 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Filippo Pietrantonio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pietrantonio's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile